Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Praxis Precision Medicines is raising $9,999,998.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Kiran Reddy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Praxis Precision Medicines

Praxis Precision Medicines, Inc. formerly known as EpiPM Therapeutics, Inc. is a developer of medicine intended to treat neurological, psychiatric, and movement disorders. The company is currently operating in Stealth mode.

To learn more about Praxis Precision Medicines, visit http://praxismedicines.com/

Contact:
Kiran Reddy, President and Chief Executive Officer
617-949-2220
kiran@praxismedicines.com
https://www.linkedin.com/in/reddykiran/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved